124 related articles for article (PubMed ID: 12516970)
1. Proof-of-principle: oncogenic beta-catenin is a valid molecular target for the development of pharmacological inhibitors.
Kim JS; Crooks H; Foxworth A; Waldman T
Mol Cancer Ther; 2002 Dec; 1(14):1355-9. PubMed ID: 12516970
[TBL] [Abstract][Full Text] [Related]
2. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
3. The suppression of colon cancer cell growth in nude mice by targeting beta-catenin/TCF pathway.
Kwong KY; Zou Y; Day CP; Hung MC
Oncogene; 2002 Nov; 21(54):8340-6. PubMed ID: 12447697
[TBL] [Abstract][Full Text] [Related]
4. beta-Catenin activates the growth factor endothelin-1 in colon cancer cells.
Kim TH; Xiong H; Zhang Z; Ren B
Oncogene; 2005 Jan; 24(4):597-604. PubMed ID: 15558022
[TBL] [Abstract][Full Text] [Related]
5. beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer.
Deng J; Miller SA; Wang HY; Xia W; Wen Y; Zhou BP; Li Y; Lin SY; Hung MC
Cancer Cell; 2002 Oct; 2(4):323-34. PubMed ID: 12398896
[TBL] [Abstract][Full Text] [Related]
6. Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion.
Usami N; Sekido Y; Maeda O; Yamamoto K; Minna JD; Hasegawa Y; Yoshioka H; Imaizumi M; Ueda Y; Takahashi M; Shimokata K
Oncogene; 2003 Sep; 22(39):7923-30. PubMed ID: 12970740
[TBL] [Abstract][Full Text] [Related]
7. Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness.
Pai R; Tarnawski AS; Tran T
Mol Biol Cell; 2004 May; 15(5):2156-63. PubMed ID: 15004225
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.
Verma UN; Surabhi RM; Schmaltieg A; Becerra C; Gaynor RB
Clin Cancer Res; 2003 Apr; 9(4):1291-300. PubMed ID: 12684397
[TBL] [Abstract][Full Text] [Related]
9. Beta-catenin and cyclin D1: connecting development to breast cancer.
Rowlands TM; Pechenkina IV; Hatsell S; Cowin P
Cell Cycle; 2004 Feb; 3(2):145-8. PubMed ID: 14712077
[TBL] [Abstract][Full Text] [Related]
10. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers.
Vécsey-Semjén B; Becker KF; Sinski A; Blennow E; Vietor I; Zatloukal K; Beug H; Wagner E; Huber LA
Oncogene; 2002 Jul; 21(30):4646-62. PubMed ID: 12096341
[TBL] [Abstract][Full Text] [Related]
11. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
12. Sulindac metabolites induce caspase- and proteasome-dependent degradation of beta-catenin protein in human colon cancer cells.
Rice PL; Kelloff J; Sullivan H; Driggers LJ; Beard KS; Kuwada S; Piazza G; Ahnen DJ
Mol Cancer Ther; 2003 Sep; 2(9):885-92. PubMed ID: 14555707
[TBL] [Abstract][Full Text] [Related]
13. Suppression of beta-catenin inhibits the neoplastic growth of APC-mutant colon cancer cells.
Roh H; Green DW; Boswell CB; Pippin JA; Drebin JA
Cancer Res; 2001 Sep; 61(17):6563-8. PubMed ID: 11522655
[TBL] [Abstract][Full Text] [Related]
14. Gut-enriched Krüppel-like factor regulates colonic cell growth through APC/beta-catenin pathway.
Stone CD; Chen ZY; Tseng CC
FEBS Lett; 2002 Oct; 530(1-3):147-52. PubMed ID: 12387883
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
Green DW; Roh H; Pippin JA; Drebin JA
J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of beta-catenin and plakoglobin in primary and metastatic human colonic carcinomas, colonic adenomas, and normal colon.
Lifschitz-Mercer B; Amitai R; Maymon BB; Shechtman L; Czernobilsky B; Leider-Trejo L; Ben-Ze'ev A; Geiger B
Int J Surg Pathol; 2001 Oct; 9(4):273-9. PubMed ID: 12574842
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling.
Pálmer HG; González-Sancho JM; Espada J; Berciano MT; Puig I; Baulida J; Quintanilla M; Cano A; de Herreros AG; Lafarga M; Muñoz A
J Cell Biol; 2001 Jul; 154(2):369-87. PubMed ID: 11470825
[TBL] [Abstract][Full Text] [Related]
18. Oncogenic beta-catenin is required for bone morphogenetic protein 4 expression in human cancer cells.
Kim JS; Crooks H; Dracheva T; Nishanian TG; Singh B; Jen J; Waldman T
Cancer Res; 2002 May; 62(10):2744-8. PubMed ID: 12019147
[TBL] [Abstract][Full Text] [Related]
19. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
[TBL] [Abstract][Full Text] [Related]
20. Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin.
Sasaki CY; Lin H; Morin PJ; Longo DL
Cancer Res; 2000 Dec; 60(24):7057-65. PubMed ID: 11156412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
